explore -WSS

explore

author：fashion 2025-08-08 05:33:08 - browse：7634

Adobe

The medical device industry is split on whether a proposed new Medicare reimbursement pathway will do anything to soothe their insurance coverage woes.

Device makers have long complained that the unclear, rocky road to payment kills innovative companies. So they were thrilled when the Trump administration proposed a rule that would have guaranteed four years of Medicare coverage of approved devices deemed “breakthroughs” by the Food and Drug Administration. They hoped private payers would follow suit. But in 2021, under a new administration and a push for more device scrutiny, the Centers for Medicare and Medicaid pulled back on the idea, promising a replacement that would streamline coverage for innovative devices while ensuring safe, high-quality care.

The pathway put forth last week, called Transitional Coverage for Emerging Technologies (TCET), is only a notice, not yet a rule that would grant CMS new powers. The program applies solely to devices that have earned a place in the FDA’s breakthrough device program, which was established to identify devices that the agency believed could provide “more effective” treatment or diagnosis of serious conditions than the current standard of care. But because those devices can be brought to market with less certainty in their benefits and risks than other products, experts said, the idea of automatic reimbursement was dicey.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： Plane’s emergency slide plummets from sky, hits Chicago home

knowledge

WSS

Presidential fundraising highlights so far: Trump brings in more than DeSantis

‘Insidious 5’ topples 'Indiana Jones' before ‘Mission: Impossible’ launches

States increasingly look to regulate hospital facility fees

Norman Reedus' Daryl Dixon

The aspartame in Diet Coke probably isn’t giving you cancer

US sending controversial cluster munitions to Ukraine until other ammo is ready: Kirby

knowledge

explore

focus

In age of alternative facts, a scholarly course on calling out crap

Resistance to cancer drugs: A new genetic explanation

DIEP, the 'gold standard' of breast reconstruction, is under threat

Suspected Gilgo Beach killer appeared 'traumatized' after arrest: Defense attorney

As demand for Covid shots wanes, Moderna seeks its next success

New warning issued for rebooking air travel after delays, cancellations

United colonoscopy coverage change 'may cost lives,' doctors say

Wisconsin governor employs partial veto to fund schools for 4 centuries

At least 13 dead in Texas as scorching temps continue

Presidential fundraising highlights so far: Trump brings in more than DeSantis

hotspot

Parents surprise family after baby discharged from NICU after 170 days

Researchers separate signal from noise in heart wearable data

Stanford updates investigation of president’s past research

Stanford president to resign after investigation of research

'Reaching a detente': STAT's Helen Branswell on covering Covid

Tulsa Race Massacre survivors and attorneys respond to dismissal of lawsuit

focus

hotspot

knowledge

hotspot